Your browser doesn't support javascript.
loading
Cocrystal Synthesis through Crystal Structure Prediction.
Abramov, Yuriy A; Iuzzolino, Luca; Jin, Yingdi; York, Gregory; Chen, Chien-Hung; Shultz, C Scott; Yang, Zhuocen; Chang, Chao; Shi, Baimei; Zhou, Tian; Greenwell, Chandler; Sekharan, Sivakumar; Lee, Alfred Y.
Afiliación
  • Abramov YA; XtalPi Inc., 245 Main Street, Cambridge, Massachusetts 02142, United States.
  • Iuzzolino L; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.
  • Jin Y; Computational and Structural Chemistry, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States.
  • York G; XtalPi, Inc., Shenzhen Jingtai Technology Co., Ltd., Futian District, Shenzhen 518100, China.
  • Chen CH; Analytical Research and Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States.
  • Shultz CS; Analytical Research and Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States.
  • Yang Z; Analytical Research and Development, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States.
  • Chang C; XtalPi, Inc., Shenzhen Jingtai Technology Co., Ltd., Futian District, Shenzhen 518100, China.
  • Shi B; XtalPi, Inc., Shenzhen Jingtai Technology Co., Ltd., Futian District, Shenzhen 518100, China.
  • Zhou T; XtalPi, Inc., Shenzhen Jingtai Technology Co., Ltd., Futian District, Shenzhen 518100, China.
  • Greenwell C; XtalPi, Inc., Shenzhen Jingtai Technology Co., Ltd., Futian District, Shenzhen 518100, China.
  • Sekharan S; XtalPi Inc., 245 Main Street, Cambridge, Massachusetts 02142, United States.
  • Lee AY; XtalPi Inc., 245 Main Street, Cambridge, Massachusetts 02142, United States.
Mol Pharm ; 20(7): 3380-3392, 2023 07 03.
Article en En | MEDLINE | ID: mdl-37279175

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Química Farmacéutica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Química Farmacéutica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos